Showing results (141-150 of 281) with videos related to

Sort By:
Pageof 29
Kidney International|April 28, 2019
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patientsClaudia Sommerer, Barbara Suwelack, Duska Dragun, et al.
Frontiers in Psychology|August 5, 2021
Scale Characteristics of Intercultural Competence Measures and the Effects of Intercultural Competence on PrejudicePetia Genkova, Christoph Daniel Schaefer, Henrik Schreiber, et al.
Science Signaling|November 3, 2016
Obligatory role for GPER in cardiovascular aging and diseaseMatthias R Meyer, Natalie C Fredette, Christoph Daniel, et al.
Scientific Reports|June 4, 2025
Crosstalk of injured podocytes with parietal epithelial cells through Wnt4/β-Catenin signalingEike Schwartze, Eva Pfister, Nicole Endlich, et al.
Kidney & Blood Pressure Research|April 15, 2015
Impact of phosphorus restriction and vitamin D-substitution on secondary hyperparathyroidism in a proteinuric mouse modelBernhard N Bohnert, Christoph Daniel, Kerstin Amann, et al.
Acta Pharmacologica Sinica|March 24, 2021
Renal effects of the serine protease inhibitor aprotinin in healthy conscious miceStefan Wörner, Bernhard N Bohnert, Matthias Wörn, et al.
Journal of Molecular and Cellular Cardiology|August 17, 2021
Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytesLili Wang, Yuko Wada, Nimer Ballan, et al.
The Journal of Clinical Investigation|December 17, 2013
Complement factor H-related hybrid protein deregulates complement in dense deposit diseaseQian Chen, Michael Wiesener, Hannes U Eberhardt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 11, 2012
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantationMarkus Guba, Johann Pratschke, Christian Hugo, et al.
Arthritis and Rheumatism|March 2, 2013
Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupusVilma Urbonaviciute, Charlotte Starke, Wiebke Pirschel, et al.
Pageof 29